Increasing use of autoinjector devices for rapid administration of drugs and medications in emergency situations, ease of usage to medically untrained people, and rising focus on single use and disposable medical devices are some key factors expected to drive market growth
According to Emergen Research, the global autoinjectors market size was USD 45.89 billion in 2020 and is expected to reach USD 170.16 billion in 2028 and register a revenue CAGR of 17.7% during the forecast period, 2021-2028.
Market Dynamics:
Autoinjectors are widely used for rapid administration of drugs and antidotes for critical situations such as nerve agent poisoning, anaphylactic shock and allergic reactions, seizures, pain relief, and for a variety of diseases. Drug-filled autoinjector devices (AID) are the primary choice during such situations and play a crucial role in emergency and mass casualty management. Drugs are delivered slowly through the autoinjector devices across a large area in the muscle which in turn increases absorption of the drug and is therefore highly effective. In addition, administration of medications and antidotes using autoinjectors is relatively painless. These key factors have led to increasing adoption of autoinjectors and are expected to significantly fuel market revenue growth over the forecast period.
Claim Your FREE Sample Copy with Table of content@ https://www.emergenresearch.com/request-sample/678
Drug and antidotes have to be administered immediately together with other first aid available at the site of event during medical emergencies and mass casualty incidents. These can be administered using several routes but such administration requires a qualified medical person. Self-administration of the drug by the affected individual is necessary as a life-saving measure during such conditions and this has led to further adoption of autoinjector devices. These injectors have been designed with a purpose to overcome limitations associated with self-administration of needle-based drug delivery device. Autoinjectors are generally single-use, disposable, and spring-loaded syringes and are available for intramuscular and subcutaneous injection. Autoinjectors are easy to use and can also be used by untrained personnel and has numerous benefits. Autoinjectors can also be used to deliver many parenteral drugs in safe and efficient way.
Benefits of these devices, reduced cost per injection, flexibility of using these prefilled syringes with enhanced convenience, and growing focus on device reliability have further boosted their adoption and are some other key factors expected to contribute to revenue growth of the market going ahead. Increasing need for effective administration of drugs and medications outside clinical settings either by patients or companions have led to development of advanced autoinjectors. However, complexity of some reusable mechanical autoinjectors and issues related to size of the autoinjectors can potentially limit their adoption and restrain market growth to a certain extent over the forecast period.
COVID-19 Impact Analysis
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Rheumatoid Arthritis Segment to Register Robust Revenue Growth:
Rheumatoid Arthritis (RA) segment is expected to register robust revenue CAGR over the forecast period attributable to increasing prevalence of rheumatoid arthritis and rising preference for autoinjectors for subcutaneous delivery of RA medications due to their numerous benefits such as easy usage, less pain, and less time-consuming to administer.
Check Our Prices@ https://www.emergenresearch.com/select-license/678
Disposable Segment to Account for Largest Revenue Share:
Disposable segment to account for largest revenue share over the forecast period owing to rising patient preference for one-use, disposable medical devices, availability of cost-effective and advanced single-use autoinjectors for various disease indications, and increasing number of launches of disposable autoinjectors designed to effectively and safely administer a variety of drugs.
North America to Lead in Terms of Revenue Share:
North America is expected to dominate other regional markets in terms of revenue share over the forecast period attributable to increasing prevalence of chronic conditions, rising incidence of allergic reactions and anaphylactic shock, availability of technologically advanced medical devices at cost-effective prices, favorable reimbursement policies, and presence of key players in the region.
Major Companies in the Market Include:
- Braun Melsungen AG
- AbbVie Inc.
- Mylan
- Eli Lilly and Company
- Ypsomed
- Amgen
- Becton, Dickinson and Company
- GlaxoSmithKline Plc
- Johnson & Johnson
- Antares Pharma
For the purpose of this report, Emergen Research has segmented the global autoinjectors market based on therapy, type, route of administration, end-use, and region:
Therapy Outlook (Revenue, USD Billion; 2018–2028)
- Rheumatoid Arthritis
- Multiple Sclerosis
- Anaphylaxis
- Diabetes
- Others
Type Outlook (Revenue, USD Billion; 2018–2028)
- Disposable
- Reusable
Route of Administration Outlook (Revenue, USD Billion; 2018-2028)
- Subcutaneous
- Intramuscular
End-Use Outlook (Revenue, USD Billion; 2018–2028)
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Home Care Settings
Click to access the Report Study, Read key highlights of the Report and Look at Projected Trends: https://www.emergenresearch.com/industry-report/autoinjectors-market
Regional Outlook (Revenue, USD Billion; 2018–2028)
- North America
- S.
- Canada
- Mexico
- Europe
- Germany
- France
- K.
- BENELUX
- Italy
- Spain
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- Middle East & Africa
- Saudi Arabia
- A.E.
- South Africa
- Turkey
- Rest of MEA
Take a Look at our Related Reports:
Ozone Generator Market By Technology (Corona Discharge, Cold Plasma, Ultraviolet, Electrolysis), By Application (Wastewater Treatment, Air Treatment, Laboratory & Medical Equipment), By End-use Industry (Industrial, Commercial, Municipal, Residential), and By Region
Tumor Genomics Market By Technique Next Generation Sequencing Technique (NGS), Polymerase Chain Reaction (PCR), Microarray, In-Situ Hybridization (ISH), Immunohistochemistry (ICH), Others (Mass Spectrometry and Flow Cytometry), By Application: Diagnostics and Monitoring, Drug Discovery and Development, Biomarker Discovery, By End use: Academics and Research Organizations, Hospitals and Ambulatory Clinics, Clinical and Diagnostic Laboratories, Biotechnology and Pharmaceutical Companies, By Region, Forecast to 2028
Oncolytic Virus Therapy Market By Type (Monoclonal Antibodies, Checkpoint Inhibitors, Cancer Vaccines, Immunomodulators), By Application (Melanoma, Lung Cancer, Breast Cancer), By End-Use (Hospitals, Clinics, Research Institutes), and By Region, Forecast to 2028
Orthopedic Biomaterial Market By Material Type (Polymers, Ceramics & Bioactive Glasses, Composites, Metal, Calcium Phosphate), By Application (Orthopedic Implants, Orthobiologics, Joint Reconstruction/Replacement, Bio-resorbable Tissue Fixation, Visco Supplementation), By End-Use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), and By Region, Forecast to 2028
Minimally Invasive Surgical Systems Market By Device Type (Handheld Devices, Cutter Devices, Inflation Devices, Electrosurgical Devices, Monitoring and Visual Devices, Guiding Devices, Auxiliary Devices), By Surgery Type (Gastrointestinal Surgery, Cardiovascular Surgery, Orthopedic Surgery, Urological Surgery, Cosmetic Surgery, Neurological Surgery), By End-Use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), and By Region Forecast to 2028
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Facebook | LinkedIn | Twitter | Blogs
Read Full Press Release: https://www.emergenresearch.com/press-release/global-autoinjectors-market